Reversal of Anticoagulation Effect of Dabigatran with Idarucizumab, for Thrombolysis in Acute Ischemic Stroke: Inimicus Inimico Amicus

被引：7
|
作者：
Maramattom, Boby V. [1 ]
Thomas, Joe [2 ]
机构：
[1] Aster Medcity, Dept Neurol, Kochi, Kerala, India
[2] Aster Medcity, Kochi, Kerala, India
来源：
ANNALS OF INDIAN ACADEMY OF NEUROLOGY | 2019年 / 22卷 / 04期
关键词：
D O I：
10.4103/aian.AIAN_536_18
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：515 / +
页数：3
相关论文
共 50 条
  • [21] Adverse clinical outcomes after dabigatran reversal with idarucizumab to facilitate acute stroke thrombolysis
    Ng, Felix C.
    Bice, James
    Rodda, Anne
    Lee-Archer, Matthew
    Crompton, Douglas E.
    JOURNAL OF NEUROLOGY, 2017, 264 (03) : 591 - 594
  • [22] Adverse clinical outcomes after dabigatran reversal with idarucizumab to facilitate acute stroke thrombolysis
    Felix C. Ng
    James Bice
    Anne Rodda
    Matthew Lee-Archer
    Douglas E. Crompton
    Journal of Neurology, 2017, 264 : 591 - 594
  • [23] Successful intravenous thrombolysis in acute ischemic stroke after reversal of dabigatran etexilate with idarucizumab at the end of therapeutic time window
    Vukorepa, Gorana
    Devedija, Sabina
    Crnjakovic, Miljenko
    Karakas, Mirna
    Cuk, Zeljka
    TURKISH JOURNAL OF EMERGENCY MEDICINE, 2020, 20 (02): : 90 - 92
  • [24] Paradoxical elevation of plasma dabigatran after reversal with idarucizumab in stroke thrombolysis
    Satoshi Hosoki
    Masahito Takagi
    Hiroshi Yamagami
    Daisuke Ando
    Kazunori Toyoda
    Masatoshi Koga
    Journal of Neurology, 2018, 265 : 2451 - 2453
  • [25] Paradoxical elevation of plasma dabigatran after reversal with idarucizumab in stroke thrombolysis
    Hosoki, Satoshi
    Takagi, Masahito
    Yamagami, Hiroshi
    Ando, Daisuke
    Toyoda, Kazunori
    Koga, Masatoshi
    JOURNAL OF NEUROLOGY, 2018, 265 (10) : 2451 - 2453
  • [26] Idarucizumab for Reversal of Dabigatran-Associated Anticoagulation
    Yogaratnam, Dinesh
    Ditch, Kristen
    Medeiros, Kristin
    Doyno, Cassandra
    Fong, Jeffrey J.
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (10) : 847 - 854
  • [27] Idarucizumab Reversal of Dabigatran in Patients with Acute Ischemic Stroke and Intracranial Hemorrhage: Comparison with Non-idarucizumab-Treated Patients
    Frol, Senta
    Sernec, Lana Podnar
    Hudnik, Liam Korosec
    Sabovic, Miso
    Oblak, Janja Pretnar
    CNS DRUGS, 2021, 35 (02) : 233 - 242
  • [28] Idarucizumab Reversal of Dabigatran in Patients with Acute Ischemic Stroke and Intracranial Hemorrhage: Comparison with Non-idarucizumab-Treated Patients
    Senta Frol
    Lana Podnar Sernec
    Liam Korošec Hudnik
    Mišo Šabovič
    Janja Pretnar Oblak
    CNS Drugs, 2021, 35 : 233 - 242
  • [29] Treatment With Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran With Idarucizumab: A Case Study
    Jala, Sheila
    O'Brien, Elizabeth
    JOURNAL OF NEUROSCIENCE NURSING, 2019, 51 (01) : 21 - 25
  • [30] Intravenous stroke thrombolysis after reversal of dabigatran effect by idarucizumab: first reported case in Hong Kong
    Lo, W. T.
    Ng, K. F.
    Chan, Simon C. H.
    Kwok, Vivian W. Y.
    Fong, C. S.
    Chan, S. T.
    Wong, Gordon C. K.
    Fong, W. C.
    HONG KONG MEDICAL JOURNAL, 2018, 24 (01) : 81 - 83
12345